AMEX · PMI
Healthcare · Medical - Devices
$7.78
Down-$0.23 (-2.96%)
Updated Nov 4, 2026, 5:58 PM
SID Score
4.5/10
Composite research score
Smart Money
58/100
Neutral
Price performance · PMI
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
PMI closed at $7.78 after 21 trading sessions, down 10.98% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $8.72 | $9.52 | $7.42 | $7.78 | 97.35K |
| Nov 2, 2026 | $8.42 | $9.14 | $8.35 | $8.58 | 41.47K |
| Oct 30, 2026 | $8.15 | $8.81 | $7.74 | $8.35 | 56.34K |
| Oct 29, 2026 | $7.14 | $8.40 | $7.12 | $8.11 | 71.09K |
| Oct 28, 2026 | $6.86 | $7.30 | $6.84 | $7.23 | 44.27K |
| Oct 27, 2026 | $6.69 | $6.9725 | $6.50 | $6.83 | 52.96K |
| Oct 26, 2026 | $7.14 | $7.305 | $6.4004 | $6.43 | 76.51K |
| Oct 23, 2026 | $7.05 | $8.30 | $7.0301 | $7.09 | 88.6K |
| Oct 22, 2026 | $9.35 | $9.53 | $7.00 | $7.37 | 331.01K |
| Oct 21, 2026 | $11.01 | $11.055 | $9.18 | $9.63 | 422.08K |
| Oct 20, 2026 | $15.20 | $17.47 | $10.14 | $10.48 | 1.01M |
| Oct 19, 2026 | $13.59 | $15.60 | $12.32 | $15.45 | 748.92K |
| Oct 16, 2026 | $12.21 | $13.1584 | $8.38 | $12.75 | 1.61M |
| Oct 15, 2026 | $13.67 | $18.23 | $10.00 | $10.00 | 1.49M |
| Oct 14, 2026 | $13.61 | $14.50 | $12.68 | $12.68 | 160.87K |
| Oct 13, 2026 | $11.22 | $17.50 | $10.5903 | $15.33 | 1.18M |
| Oct 12, 2026 | $9.15 | $12.69 | $9.0125 | $11.34 | 693.87K |
| Oct 9, 2026 | $9.51 | $9.72 | $8.15 | $9.48 | 300.94K |
| Oct 8, 2026 | $9.29 | $10.10 | $8.85 | $9.68 | 259.12K |
| Oct 7, 2026 | $8.70 | $10.1933 | $7.63 | $9.37 | 792.51K |
| Oct 6, 2026 | $6.80 | $9.00 | $6.69 | $8.74 | 912.71K |
The latest Smart Investors Daily articles mentioning PMI.
Company
Market Activity
Research & News
PMI research
Company profile and research snapshot.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 3, 2026 | HC Wainwright & Co. | Neutral | — |
| May 18, 2026 | HC Wainwright & Co. | Neutral | — |
No generated briefing is available yet.
Benzinga · Oct 20, 2026
Gainers XORTX Therapeutics (NASDAQ:XRTX) shares moved upwards by 19.3% to $1.14 during Tuesday's after-market session. The company's market cap stands at $1.8 million. Edesa Biotech (NASDAQ:EDSA) shares rose
ChartMill · Oct 19, 2026
See the largest gap-up and gap-down stocks for Oct. 19, 2026, including SLN, YMAT, IRON, CLF, GLAS and other session movers.
ChartMill · Oct 13, 2026
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Benzinga · Oct 13, 2026
Gainers Alaunos Therapeutics (NASDAQ:TCRT) stock moved upwards by 203.8% to $3.19 during Tuesday's regular session. The company's market cap stands at $2.6 million. Picard Medical (AMEX:PMI) stock moved
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PMI.
